Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.
about
A Novel Prolyl Endopeptidase Inhibitor, JTP-4819 - Its Behavioral and Neurochemical Properties for the Treatment of Alzheimer's DiseasePharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I study.Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's diseaseNeuropeptides and Alzheimer's disease.Vasopressin response to dehydration in Alzheimer's disease.
P2860
Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.
description
1987 nî lūn-bûn
@nan
1987 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Reduction of arginine-vasopres ...... lzheimer type senile dementia.
@ast
Reduction of arginine-vasopres ...... lzheimer type senile dementia.
@en
type
label
Reduction of arginine-vasopres ...... lzheimer type senile dementia.
@ast
Reduction of arginine-vasopres ...... lzheimer type senile dementia.
@en
prefLabel
Reduction of arginine-vasopres ...... lzheimer type senile dementia.
@ast
Reduction of arginine-vasopres ...... lzheimer type senile dementia.
@en
P2093
P2860
P356
P1476
Reduction of arginine-vasopres ...... lzheimer type senile dementia.
@en
P2093
P2860
P304
P356
10.1136/JNNP.50.7.929
P407
P577
1987-07-01T00:00:00Z